These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 6778416
1. [Pharmacokinetics of anti-arrhythmics. 2. Clinical applications]. Lévy RH, Lévy S, Bricaud H. Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1229-35. PubMed ID: 6778416 [Abstract] [Full Text] [Related]
2. Clinical pharmacokinetics of some antiarrhythmic drugs. Ochs HR, Greenblatt DJ, Bodem G. Herz; 1979 Aug; 4(4):330-43. PubMed ID: 391683 [No Abstract] [Full Text] [Related]
3. Pharmacokinetics of antiarrhythmic drugs. Kock-Weser J. Cardiovasc Clin; 1975 Aug; 7(2):191-202. PubMed ID: 1104167 [No Abstract] [Full Text] [Related]
5. [Pharmacokinetics of the principal anti-arrhythmia agents]. Derrida JP, Chiche P. Coeur Med Interne; 1978 Aug; 17(1):79-88. PubMed ID: 25160 [No Abstract] [Full Text] [Related]
6. Cardiac drug overdose. Drake CE. Am Fam Physician; 1982 Jan; 25(1):181-7. PubMed ID: 7055025 [Abstract] [Full Text] [Related]
7. Series on pharmacology in practice. 2. Antiarrhythmic drug therapy. Federman J, Vlietstra RE. Mayo Clin Proc; 1979 Aug; 54(8):531-42. PubMed ID: 459565 [Abstract] [Full Text] [Related]
8. [Pharmacokinetics of the principal anti-arrhythmic drugs. Measurement of their blood levels]. Cheymol G, Bernheim C, Jaillon P. Therapie; 1976 Aug; 31(2):149-65. PubMed ID: 951673 [No Abstract] [Full Text] [Related]
9. Pharmacokinetics of antiarrhythmic drugs. Woosley RL, Shand DG. Am J Cardiol; 1978 May 22; 41(6):986-95. PubMed ID: 352124 [Abstract] [Full Text] [Related]
10. [Determination of plasma concentrations of anti-arrhythmia agents]. Flouvat B. Arch Mal Coeur Vaiss; 1981 Dec 22; 74 Spec No():47-55. PubMed ID: 6803701 [Abstract] [Full Text] [Related]
11. Metabolites of antiarrhythmic drugs: are they clinically important? Kates RE. Ration Drug Ther; 1986 May 22; 20(5):1-5. PubMed ID: 3097754 [No Abstract] [Full Text] [Related]
12. [Clinical pharmacology of anti-arrhythmia agents. I. Quinidine, procainamide and disopyramide]. Witkowska M. Kardiol Pol; 1981 May 22; 24(7):505-17. PubMed ID: 7024612 [No Abstract] [Full Text] [Related]
13. Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents. Woosley RL, Echt DS, Roden DM. Am J Cardiol; 1986 Jan 31; 57(3):25B-33B. PubMed ID: 3080860 [Abstract] [Full Text] [Related]
15. Interaction of antacids with antiarrhythmics. V. Effect of aluminium hydroxide and magnesium oxide on the bioavailability of quinidine, procainamide and propranolol in dogs. Remon JP, Belpaire F, Van Severen R, Braeckman P. Arzneimittelforschung; 1983 Jan 31; 33(1):117-20. PubMed ID: 6681962 [Abstract] [Full Text] [Related]
17. Binding of antiarrhythmic drugs to human placenta in vitro. Bailey DN. Ann Clin Lab Sci; 1999 Jan 31; 29(3):209-12. PubMed ID: 10440585 [Abstract] [Full Text] [Related]